title: Vitreomacular adhesion and neovascular age-related macular degeneration.
authors.affiliation: Retina Specialists, Towson, Maryland.
authors.forename: John T
authors.initials: JT
authors.lastname: Thompson
mesh_terms: D000369:Aged, 80 and over; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use; D001485:Basement Membrane / Q000473:pathology; D000068258:Bevacizumab; D020256:Choroidal Neovascularization / Q000188:drug therapy / Q000209:etiology*; D005341:Fibrinolysin / Q000494:pharmacology; D022001:Focal Adhesions / Q000187:drug effects / Q000473:pathology*; D006801:Humans; D008268:Macular Degeneration / Q000188:drug therapy / Q000209:etiology*; D008297:Male; D010446:Peptide Fragments / Q000494:pharmacology; D012160:Retina / Q000378:metabolism / Q000473:pathology*; D012307:Risk Factors; D041623:Tomography, Optical Coherence; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors; D014792:Visual Acuity; D014822:Vitreous Body / Q000187:drug effects / Q000378:metabolism / Q000473:pathology*
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; D010446:Peptide Fragments; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A; D000068258:Bevacizumab; C054561:microplasmin; D005341:Fibrinolysin